John D Lloyd Still

Summary

Publications

  1. ncbi request reprint Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study
    John D Lloyd-Still
    Rush University Medical Center, Chicago, Illinois, USA
    Nutrition 22:36-46. 2006
  2. ncbi request reprint Essential fatty acid deficiency and nutritional supplementation in cystic fibrosis
    John D Lloyd-Still
    J Pediatr 141:157-9. 2002

Collaborators

Detail Information

Publications2

  1. ncbi request reprint Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study
    John D Lloyd-Still
    Rush University Medical Center, Chicago, Illinois, USA
    Nutrition 22:36-46. 2006
    ..The study objective was to determine bioavailability, tissue accretion, and safety of a large dose of an algal source of docosahexaenoic acid (DHA) triacylglycerol and to observe effects on lung function in patients with CF...
  2. ncbi request reprint Essential fatty acid deficiency and nutritional supplementation in cystic fibrosis
    John D Lloyd-Still
    J Pediatr 141:157-9. 2002